source
- FDA staff raise concerns over data for Moderna’s mFlusiva flu vaccine ahead of advisory panelFDA staff have examined the evidence for Moderna's mFlusiva, an mRNA flu vaccine, and highlighted shortcomings in the data submitted to the agency. The Food and Drug Administration will convene an…
- Medicare rule could bring subcutaneous Keytruda and Opdivo under price negotiationsA federal rule proposed for 2029 aims to close a loophole that currently shields medicines moving from intravenous to subcutaneous administration from Medicare price negotiations. The Centers for M…